Molecular Disease Profile of Hematological Malignancies
Condition(s):Hematological MalignanciesLast Updated:June 8, 2015Unknown status
Hide Studies Not Open or Pending
Condition(s):Hematological MalignanciesLast Updated:June 8, 2015Unknown status
Condition(s):Hematological MalignancyLast Updated:December 26, 2018Unknown status
Condition(s):Hematologic MalignancyLast Updated:March 5, 2024Recruiting
Condition(s):CXCR4; PET/CT; Hematological MalignancyLast Updated:December 1, 2022Recruiting
Condition(s):Hematologic MalignancyLast Updated:August 15, 2023Recruiting
Condition(s):Advanced Solid Tumors; Hematological MalignanciesLast Updated:September 11, 2023Recruiting
Condition(s):Hematological MalignanciesLast Updated:March 6, 2023Recruiting
Condition(s):Lymphoid Hematological Malignancies; Relapsed and Refractory Multiple MyelomaLast Updated:February 27, 2018Terminated
Condition(s):COVID-19 Infection in Hematological Malignancies PatientsLast Updated:November 22, 2023Recruiting
Condition(s):Hematological MalignanciesLast Updated:November 21, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.